Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy
Sponsor: Karolinska University Hospital
Summary
Prospective observational cohort study including patients with a diagnosis of intrahepatic/perihilar cholangiocarcinoma at the central regional multidisciplinary conference, to assess therapy response, patient-reported quality of life, patient-reported symptoms/experiences and biomarkers. For patients diagnosed with localized unresectable disease, the study will document the multidisciplinary re-assessment of therapy response.
Official title: The Re-ACT Study: Prognostic Evaluation and Systematic Re-Assessment of Chol- Angiocarcinoma Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
900
Start Date
2026-09
Completion Date
2031-12
Last Updated
2026-09-11
Healthy Volunteers
Not specified